Sarda Proteins
Ticker > Company >

Sarda Proteins share price

Sarda Proteins Ltd.

BSE: 519242 SECTOR: Edible Oil  7.63 K   2   0

100.90
-5.30 (-4.99%)
BSE: 20 Oct 4:00 PM

Price Summary

Today's High

₹ 100.9

Today's Low

₹ 100.9

52 Week High

₹ 144.3

52 Week Low

₹ 100.9

FinStar is Suspended!

The FinStar rating for this company is currently unavailable due to limited data disclosure. As a micro-cap company, it may carry higher risk and limited transparency. We will update the FinStar rating once more reliable data becomes available.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 17.41 Cr.

Enterprise Value

₹ 17.3 Cr.

No. of Shares

0.17 Cr.

P/E

0

P/B

15.7

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  6.43

CASH

₹ 0.12 Cr.

DEBT

₹ 0 Cr.

Promoter Holding

0 %

EPS (TTM)

₹  -2.35

Sales Growth

-77.64%

ROE

1.23 %

ROCE

0.8%

Profit Growth

158.79 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year-77.64%
3 Year-51.5%
5 Year-29.07%

Profit Growth

1 Year158.79%
3 Year43.54%
5 Year16.62%

ROE%

1 Year1.23%
3 Year6.77%
5 Year4.25%

ROCE %

1 Year0.8%
3 Year5.72%
5 Year5.71%

Debt/Equity

0

Price to Cash Flow

-75.43

Interest Cover Ratio

160.9661

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Jun 2025 0.00 0.00
Mar 2025 0.00 0.00
Dec 2024 0.00 0.00
Sep 2024 0.00 0.00
Jun 2024 0.00 0.00
Investors List
* Figures given above are % of equity capital

 Strengths

  • Company is virtually debt free.
  • The company has an efficient Cash Conversion Cycle of 0 days.
  • Company has a healthy liquidity position with current ratio of 124.6461.

 Limitations

  • The company has shown a poor revenue growth of -51.5020180750895% for the Past 3 years.
  • Company has a poor ROE of 6.76526942058587% over the past 3 years.
  • Company has negative cash flow from operations of -0.23086.
  • The company has a low EBITDA margin of -1.93626899626125% over the past 5 years.
  • The company is trading at a high PE of 0.

Quarterly Result (All Figures in Cr.)

PARTICULARS Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025
Net Sales 0 0.14 24.05 0 10.96
Total Expenditure 0.08 0.04 23.96 0.1 11.45
Operating Profit -0.08 0.11 0.1 -0.1 -0.49
Other Income 0 0 0 0 0
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax -0.08 0.11 0.1 -0.1 -0.49
Tax 0 0 0 0.02 0
Profit After Tax -0.08 0.11 0.1 -0.11 -0.49
Adjusted EPS (Rs) -0.46 0.61 0.56 -0.65 -2.86

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 5.4 11.36 10.76 5.8 1.3
Total Expenditure 5.3 11.38 10.49 5.94 1.44
Operating Profit 0.1 -0.02 0.27 -0.15 -0.15
Other Income 0.08 0.08 0.09 0.16 0.17
Interest 0 0 0 0 0
Depreciation 0 0 0 0 0
Exceptional Items 0 0 0 0 0
Profit Before Tax 0.17 0.06 0.35 0.01 0.02
Tax 0.14 0.08 0.05 0.05 0
Net Profit 0.03 -0.02 0.31 -0.03 0.02
Adjusted EPS (Rs.) 0.19 -0.12 1.78 -0.19 0.11

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 2.5 2.5 2.5 2.5 2.5
Total Reserves -0.41 -0.43 -0.12 -0.15 -0.13
Borrowings 0 0 0 0 0
Other N/C liabilities -0.29 -0.21 -0.15 -0.11 -0.09
Current liabilities 0.04 0.03 0.04 0.02 0.02
Total Liabilities 1.85 1.91 2.27 2.27 2.3
Assets
Net Block 0.01 0.01 0 0 0
Capital WIP 0 0 0 0 0
Intangible WIP 0 0 0 0 0
Investments 0 0 0 0 0
Loans & Advances 0 0 0 0 0
Other N/C Assets 0 0 0 0 0
Current Assets 1.84 1.9 2.27 2.27 2.3
Total Assets 1.85 1.91 2.27 2.27 2.3
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.17 0.06 0.35 0.01 0.02
Adjustment -0.07 -0.08 -0.08 -0.16 -0.16
Changes in Assets & Liabilities -0.12 -0.02 -0.17 -0.15 -0.09
Tax Paid -0.03 -0.01 0 0 0
Operating Cash Flow -0.05 -0.05 0.1 -0.3 -0.23
Investing Cash Flow 0.09 0.08 0.09 0.16 0.17
Financing Cash Flow -0.01 0 0 0 0
Net Cash Flow 0.03 0.03 0.19 -0.14 -0.07

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 28.41 28.41 28.41 28.41 28.41
ajay data 2.03 2.03 2.03 2.03 2.03
babu lal data 3.67 3.67 3.67 3.67 3.67
deepak data 2.03 2.03 2.03 2.03 2.03
mohini devi 0.87 0.87 0.87 0.87 0.87
nidhie a data - 0.87 0.87 0.87 0.87
ritika data 0.87 0.87 0.87 0.87 0.87
ritika vegetable oil priv... 18.08 18.08 18.08 18.08 18.08
nidhi data 0.87 - - - -
PARTICULARS Jun 2024% Sep 2024% Dec 2024% Mar 2025% Jun 2025%
investors 100.00 100.00 100.00 100.00 100.00
arix capital limited 2.43 2.43 2.43 2.43 2.43
guttikonda rajasekhar 1.86 1.86 1.86 1.86 1.86
guttikonda vara lakshmi 3.57 3.57 3.57 3.57 3.57
jainam uday shah 3.13 3.13 3.13 3.13 3.13
jinal vijay shah 1.16 1.16 1.16 1.16 1.16
kanta devi samdaria 4.03 4.03 4.03 4.03 4.03
manoj kumar kanda - 1.33 2.46 2.62 2.98
millennium stock broking ... - 1.03 1.03 1.03 1.03
mishra sangeeta rajesh 1.10 1.10 1.10 1.10 1.10
neelima karlapudi 2.63 2.63 2.63 2.63 2.63
preeti bhauka - 1.55 1.55 1.55 1.55
vivek kumar bhauka - 1.04 1.04 1.04 1.60
llp 0.01 0.64 0.64 0.64 -
uday r shah (huf) - 4.26 4.26 4.26 -
atul pratap shah 1.76 - - - -
gopalkumar bhikhalal bald... 2.01 - - - -
kajal gopal baldha 1.75 - - - -
punitbhai bavanjibhai lak... 1.43 - - - -

Annual Reports

Title Link
Title Link
Annual Report 2019
Annual Report 2018
Annual Report 2017

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Company News

Sarda Proteins informs about confirmation certificate 14 Oct, 5:04 PM Sarda Proteins - Quaterly Results 14 Aug, 5:05 PM Sarda Proteins - Quaterly Results 14 Aug, 5:05 PM Sarda Proteins - Quaterly Results 15 May, 5:37 PM Sarda Proteins - Quaterly Results 15 May, 5:37 PM Sarda Proteins informs about outcome of board meeting 10 Mar, 12:55 PM Sarda Proteins - Quaterly Results 17 Jan, 4:46 PM Sarda Proteins - Quaterly Results 17 Jan, 4:46 PM Sarda Proteins - Quaterly Results 17 Jan, 4:46 PM Sarda Proteins - Quaterly Results 9 Nov, 12:00 PM Sarda Proteins - Quaterly Results 9 Nov, 12:00 PM Sarda Proteins - Quaterly Results 9 Nov, 12:00 PM Sarda Proteins - Quaterly Results 12 Aug, 5:58 PM Sarda Proteins - Quaterly Results 12 Aug, 5:58 PM Sarda Proteins informs about disclosure 4 Jun, 4:56 PM Sarda Proteins informs about disclosure 4 Jun, 4:45 PM Sarda Proteins informs about disclosure 17 May, 2:03 PM Sarda Proteins informs about disclosures 15 May, 6:17 PM Sarda Proteins - Quaterly Results 30 Apr, 6:53 PM Sarda Proteins - Quaterly Results 30 Apr, 6:53 PM Sarda Proteins informs about disclosure 3 Apr, 5:20 PM Sarda Proteins - Quaterly Results 13 Feb, 5:32 PM Sarda Proteins - Quaterly Results 13 Feb, 5:32 PM Sarda Proteins informs about appointment of CFO 1 Dec, 2:09 PM Sarda Proteins - Quaterly Results 7 Nov, 5:19 PM Sarda Proteins informs about scrutinizer’s report 30 Sep, 3:14 PM Sarda Proteins informs about non-applicability of large corporate entity 4 Apr, 2:13 PM Sarda Proteins informs about closure of trading window 30 Mar, 2:05 PM Sarda Proteins informs about loss of share certificate 23 Feb, 2:18 PM Sarda Proteins informs about appointment of CFO 30 Jan, 4:34 PM Sarda Proteins - Quaterly Results 30 Jan, 2:11 PM Sarda Proteins - Quaterly Results 30 Jan, 2:11 PM Sarda Proteins - Quaterly Results 30 Jan, 2:11 PM Sarda Proteins - Quaterly Results 19 Oct, 1:56 PM Sarda Proteins - Quaterly Results 19 Oct, 1:56 PM Sarda Proteins - Quaterly Results 19 Oct, 1:56 PM Sarda Proteins informs about annual report 25 Aug, 4:52 PM Sarda Proteins - Quaterly Results 5 Aug, 2:06 PM Sarda Proteins - Quaterly Results 5 Aug, 2:06 PM Sarda Proteins - Quaterly Results 5 Aug, 2:06 PM Sarda Proteins informs about closure of trading window 31 Mar, 2:59 PM Sarda Proteins informs about press release 11 Feb, 12:08 PM Sarda Proteins - Quaterly Results 10 Feb, 2:07 PM Sarda Proteins - Quaterly Results 10 Feb, 2:07 PM Sarda Proteins - Quaterly Results 10 Feb, 2:07 PM Sarda Proteins informs about closure of trading window 31 Dec, 2:11 PM Sarda Proteins informs about voting results 18 Sep, 5:07 PM Sarda Proteins informs about board meeting 3 Aug, 5:00 PM Sarda Proteins informs about newspaper advertisement 26 Aug, 12:38 PM
Last Updated on:
Brief about Sarda Proteins
X